Navigation Links
CHPA Applauds New Mexico Adoption Of House Bill 146
Date:3/16/2013

WASHINGTON, March 16, 2013 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) today applauded the New Mexico legislature for passing House Bill 146, an anti-methamphetamine bill authored by Representative Antonio "Moe" Maestas (D-16).  Once Governor Susana Martinez (R-N.M.) signs the bill into law, New Mexico will become the 27th state to adopt electronic pseudoephedrine (PSE) sales blocking technology.

Real-time, stop-sale technology is a proven and powerful tool that allows retailers and pharmacists to block unlawful attempted purchases of cold and allergy medicines containing PSE that exceed daily or monthly limits established by the 2005 Combat Methamphetamine Epidemic Act. While law-abiding consumers make the vast majority of PSE purchases, some hardened criminals illegally obtain these products in order to manufacture meth. Illegal sales blocking technology empowers retailers and law enforcement officials with the ability to track and block illegal sales of products containing PSE before they happen. Before this technology was in place, retailers had to manually record PSE purchases in a hand-written logbook—a cumbersome and ineffective system for preventing unlawful sales. Real-time, stop-sale technology is also a useful tool for police officers and narcotics agents. Law enforcement officials have instant access to PSE purchasing activity which can help determine if a suspect is purchasing PSE in order to manufacture meth.. The system is provided at no charge to the state.

"Shortly after Governor Martinez signs this important legislation into law, more than half the nation will be covered by pseudoephedrine tracking technology," said Scott Melville , president and chief executive officer of the Consumer Healthcare Products Association. "In addition to New Mexico, twenty-six states have chosen to adopt real-time, stop-sale technology because in addition to providing an exceptional resource to law enforcement and retailers, the technology ensures that law-abiding consumers continue to have access to the cold and allergy medicines they know and trust. More than 18 million American families rely on safe and effective medicines containing pseudoephedrine for relief from symptoms. We commend Representative Maestas for advancing legislation that targets criminals, not responsible New Mexico taxpayers."

CHPA is the 132-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.

chpa-info.org


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Applauds GPhA Study Demonstrating $1 Trillion in Prescription Drug Savings from Generic Medicines
2. Mylan Applauds Study Highlighting $1 Trillion in Savings for U.S. Health Care System Due to Generic Drugs Over Past Decade
3. CRN Applauds Introduction Of Designer Anabolic Steroid Control Act
4. ADVENTRX Applauds Inclusion of Rare Diseases Provisions in the FDA Safety and Innovation Act
5. Mylan Applauds Signing of Landmark "Food and Drug Administration Safety and Innovation Act"
6. American Academy of Pain Medicine Applauds FDA Action to Enhance Patient Safety on Prescribing Opioids; Offers AAPM Safe Opioid Prescribing Course as Educational Model
7. Novation Applauds FDAs Unique Device Identification Rule
8. Obesity Care Continuum (OCC) Applauds FDA for Approval of New Obesity Drug
9. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
10. CHPA Applauds Arizonas Adoption Of HB 2263
11. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Ind. , Feb. 24, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the Cowen ... at the Boston Marriott Copley Place on Tuesday, March ... A live webcast of the presentation can be ... archived for replay following the conference via Zimmer Biomet,s ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Dry ... offering. ... Dry eye Drugs Price Analysis and Strategies - 2016, provides drug pricing ... answers the following questions: What are the ... they positioned in the Global Dry eye market? What ...
(Date:2/24/2017)... CHAPEL HILL, N.C. , Feb. 24, 2017 ... sector are exploring ways to increase their self-service ... as Health Care Providers (HCPs). New ... that many pharma organizations have developed self-service website ... questions electronically.  This is just one of many ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Anahata Ananda of Shamangelic ... happy to announce her “Spring Rejuvenation in Sedona” personally tailored retreats. For those ... the winter-weary soul an excellent opportunity to come out of hibernation and do ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... provides an overview on laser diffraction analysis as a tool to characterize particle ... significance and potential to obtain improved results and novel scientific findings. It describes ...
(Date:2/27/2017)... Francisco, CA (PRWEB) , ... February 27, 2017 ... ... center for hair transplantation therapy, is proud to announce a new informational post ... hair therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation ...
(Date:2/26/2017)... ... 26, 2017 , ... This is an extension of airmid’s ... be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite allergen) ... recognised standard that sets out requirements for the technical competence of testing and ...
(Date:2/26/2017)... ... ... ODH, Inc.™ announced today it will exhibit and speak at the 10th ... Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present on how ... management. , ODH will also have an exhibit booth where attendees may speak to ...
Breaking Medicine News(10 mins):